Experts share how much sleep teenagers need and why. Plus, tips to help teens sleep better.

Children and adolescents with diabetes using inhaled insulin had an increase in HbA1c from baseline to 1 year, according to data from the INHALE-1 extension trial published in Diabetes Technology & ...

The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with idiopathic short stature, short stature born small for gestational age, or ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

It joins the CNP analog vosoritide (Voxzogo), a once-daily injection, as the only treatments approved for achondroplasia. Other treatments include growth hormone injections, limb-lengthening surgery, ...

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Few topics provoke as much concern as the perception that puberty is beginning earlier than ever. While synthetic ...

Novo Nordisk A/S (NYSE:NVO) is one of the best cheap stocks under $50 to buy right now. Novo Nordisk A/S (NYSE:NVO) announced ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...